|
GIST Support International - GIST In the News
FDA Approves Adjuvant Imatinib |
| Posted by Julie Royster (juliecontent) on Dec 20 2008 |
On December 19, 2008 the US FDA announced approval of the use of imatinib (Gleevec) as adjuvant treatment (prescribed after complete surgical resection) to prevent recurrence of GIST. Below is a link to the brief announcement. More details should emerge soon.
http://www.fda.gov:80/bbs/topics/NEWS/2008/NEW01931.html
Last changed: Dec 20 2008 at 11:10 AM
Back
